Greenberg A H, Manougian J, Ray M, Goldenberg G J
Acta Cytol. 1980 May-Jun;24(3):232-6.
A mutant of the uniformly lethal L5178Y lymphoma, called the L5178Y/Manitoba (L5178Y/M), was rejected after subcutaneous challenge in syngeneic DBA/2 mice. Karyotypic analysis revealed that the parent L5178Y lymphoma had four chromosome markers, with the mutant L5178Y/M sharing one of them as well as possessing two distinguishing markers. One diploid and two hypotetraploid clones were isolated from the L5178Y/M; they contained all the marker chromosomes and were also rejected by the syngeneic host. In addition to the shared chromosome markers, the L5178Y/M possessed antigens in common with the parent L5278Y. DBA/2 mice made immune to the mutant by subcutaneous immunization were able to slow the growth of the parent tumor but not the unrelated P-815-X2 mastocytoma.
一种名为L5178Y/曼尼托巴(L5178Y/M)的一致致死性L5178Y淋巴瘤突变体,在同基因DBA/2小鼠皮下接种后被排斥。核型分析显示,亲本L5178Y淋巴瘤有四个染色体标记,突变体L5178Y/M共享其中一个标记,同时还拥有两个独特的标记。从L5178Y/M中分离出一个二倍体克隆和两个亚四倍体克隆;它们包含所有标记染色体,也被同基因宿主排斥。除了共享的染色体标记外,L5178Y/M还拥有与亲本L5278Y共有的抗原。通过皮下免疫对突变体产生免疫的DBA/2小鼠能够减缓亲本肿瘤的生长,但对无关的P-815-X2肥大细胞瘤则没有作用。